PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 26 | -98.9% | 0.00% | -100.0% |
| Q3 2021 | $43,000 | +115.0% | 2,450 | +444.4% | 0.01% | +175.0% |
| Q2 2021 | $20,000 | -75.9% | 450 | -85.9% | 0.00% | -78.9% |
| Q1 2021 | $83,000 | +245.8% | 3,200 | +166.7% | 0.02% | +216.7% |
| Q4 2020 | $24,000 | +500.0% | 1,200 | +500.0% | 0.01% | +500.0% |
| Q3 2020 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -63.6% | 200 | -86.7% | 0.00% | -75.0% |
| Q1 2020 | $11,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |